Dawn Laney MS/CGC
- Department of Human Genetics
Associate Professor
- (404) 778-8518
- dawn.laney@emory.edu
-
101 Woodruff Circle
Suite 7130
Atlanta, GA 30322
Overview
Ms. Laney is a genetic counselor, associate professor, researcher, director of the Genetic Clinical Trials Center, and program leader of the Emory Lysosomal Storage Disease Center at Emory University in the Department of Human Genetics. Ms. Laney received her masters degree in medical genetics from Sarah Lawrence College in 1999. She received her certification from the American Board of Genetic Counseling in 2002. Since joining the Emory Division of Medical Genetics in 2002, Ms. Laney has been involved in the follow-up of abnormal metabolic newborn screening for the state of Georgia development, and management of a genetic infusion center, and lysosomal storage disease clinical care and research.
As well as being the Emory Lysosomal Storage Disease Center Program Lead and Emory Genetic Clinical Trials Center Director, Ms. Laney also serves on the Emory Biomedical IRB Committee and teaches Developmental Biology and Human Malformation course (HGC 725).
Ms. Laney's main clinical research interests are in the lysosomal storage diseases, particularly Fabry disease, with emphasis on elucidation of natural history, exploration of psychological disease manifestations and treatment, assisting with the transition from childhood to adulthood, clarifying disease information provision to patients/families, finding mechanisms to facilitate testing at-risk family members, and delineating disease-related reproductive issues. She is also deeply interested in genetic education and the creation of new resources for patients/families living with genetic conditions and healthcare providers.
Academic Appointment
- Associate Professor, Human Genetics, Emory University
- Assistant Professor, Human Genetics, Emory School of Medicine
- Research Interviewer, Emory University Hospital
- Genetic Counselor, Childrens Healthcare of Atlanta
- Genetic Counselor, Emory School of Medicine
Education
Degrees
- M.S. from Sarah Lawrence College
- BA from Trinity College
Research
Focus
- My clinical research interest is in the lysosomal storage diseases, particularly Fabry disease, with emphasis on elucidation of natural history, exploration of psychological disease manifestations and treatment, assisting with transition from childhood to adulthood, clarifying disease information provision to patients/families, finding mechanisms to facilitate testing at risk family members, and delineating disease related reproductive issues.
Publications
-
Benefits, limitations, and impacts of reproductive carrier screening and telehealth-based genetic counseling for individuals with an increased chance to have a child with agenetic condition.
J Genet Couns Volume: 34 Page(s): e70002
06/01/2025 Authors: Hardy MW; Bruder K; Rosen A; Ali N; Laney D; Moore RH; Rose E; Sun Y; Grinzaid KA -
Health care providers' experiences with genetic testing in patients at risk for hereditary angioedema.
J Allergy Clin Immunol Glob Volume: 4 Page(s): 100445
05/01/2025 Authors: Laney DA; Lee TD; Druss J; O'Keefe RL; Engel P; Riedl M -
A study to identify individuals at risk to be affected by late-onset Pompe disease who had previously been given a non-specific or tentative diagnosis for their muscle weakness (Pompe PURSUE).
Orphanet J Rare Dis Volume: 20 Page(s): 23
01/14/2025 Authors: Laney DA; Banks KA; Botha EG; Keever M; Long V; Foley AL -
Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondents.
Orphanet J Rare Dis Volume: 19 Page(s): 153
04/11/2024 Authors: Berry L; Walter J; Johnson J; Alton J; Powers J; Llria X; Koulinska I; McGee M; Laney D -
Prospective characterization of early symptom onset and progression in young pediatric patients with variants in the G LA gene across 5 years: Longitudinal data from the Fabry MOPPet Study.
Genet Med Open Volume: 2 Page(s): 101891
01/01/2024 Authors: Laney DA; Houde MF; Foley AL; Peck DS; Atherton AM; Manwaring LP; Grange DK; Heese BA; Holida MD; Quillin AL -
FDrisk: development of a validated risk assessment tool for Fabry disease utilizing electronic health record data.
J Rare Dis (Berlin) Volume: 3 Page(s): 2
01/01/2024 Authors: Lobel CJ; Laney DA; Yang J; Jacob D; Rickheim A; Ogg CZ; Clynes D; Dronen J -
Patient-reported experiences with Fabry disease monitoring and disease burden in the real-world setting: Results from a doubleblind, cross-sectional survey
Volume: 138 Page(s): 16 - 17
02/01/2023 Authors: Berry L; Johnson J; Alton J; Lloria X; Koulinska I; Laney DA -
Validation of a suspicion index to identify patients at risk for hereditary angioedema.
J Allergy Clin Immunol Glob Volume: 2 Page(s): 76 - 78
02/01/2023 Authors: Shams M; Laney DA; Jacob DA; Yang J; Dronen J; Logue A; Rosen A; Riedl M -
A study to identify individuals at risk to be affected by Pompe disease who had previously been given a non-specific or tentative diagnosis for their muscle weakness (Pompe PURSUE)
Volume: 135 Page(s): S103 - S103
02/03/2022 Authors: Quirin KA; Botha EG; Keever M; Long V; Foley AL; Laney DA -
Possible increased incidence of pathogenic GALC deletions in exons 11-17 causing infantile onset Krabbe disease in individuals from Ahmadabad in the Indian state of Gujarat
Volume: 135 Page(s): S70 - S70
02/03/2022 Authors: Laney DA; Black E; Russo RS